10-K Filing

GLOBAL MEDICAL REIT INC. CIK: 1533615 FY 2013

Filing Information

Form Type	10-K
Accession Number	`0001078782-13-002376`
Period End Date	20130831
Filing Date	20131129
Fiscal Year	2013
Fiscal Period	FY
XBRL Instance	scoo-20130831.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 28 Income Statement 13 Cash Flow Statement 38 Stockholders Equity 13

Balance Sheet 28 line items

Line Item	Tag	Value	Unit	Period
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common Stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash	`Cash`	$12.31K	USD	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common Stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash	`Cash`	$3.52K	USD	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	5.50M	shares	Point-in-time
Common Stock, shares issued	`CommonStockSharesIssued`	8.00M	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$3.52K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$12.31K	USD	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	8.00M	shares	Point-in-time
Common Stock, shares outstanding	`CommonStockSharesOutstanding`	5.50M	shares	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$19.04K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$7.50K	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	$380.00	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$19.42K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$7.88K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001. 8,000,000 and 5,500,000 share issued and outstanding as of August 31, 2013 and 2012, respectively	`CommonStockValue`	$5.50K	USD	Point-in-time
Common stock Authorized: 200,000,000 shares, par value $0.001. 8,000,000 and 5,500,000 share issued and outstanding as of August 31, 2013 and 2012, respectively	`CommonStockValue`	$8.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$72.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$49.50K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-50.57K	USD	Point-in-time
Deficit accumulated during the development stage	`DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage`	$-95.91K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-15.90K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$4.43K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$12.31K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$3.52K	USD	Point-in-time

Income Statement 13 line items

Line Item	Tag	Value	Unit	Period
General and administrative	`GeneralAndAdministrativeExpense`	$95.91K	USD	10 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$45.34K	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$50.11K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$50.11K	USD	Annual
Total Operating Expenses	`OperatingExpenses`	$95.91K	USD	10 Qtrs
Total Operating Expenses	`OperatingExpenses`	$45.34K	USD	Annual
Net Loss	`NetIncomeLoss`	$-50.11K	USD	Annual
Net Loss	`NetIncomeLoss`	$-45.34K	USD	Annual
Net Loss	`NetIncomeLoss`	$-95.91K	USD	10 Qtrs
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$0.01	USD	Annual
Net Loss Per Share - Basic and Diluted	`EarningsPerShareBasicAndDiluted`	$0.01	USD	Annual
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.83M	shares	Annual
Weighted Average Shares Outstanding	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	5.50M	shares	Annual

Cash Flow Statement 38 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-45.34K	USD	Annual
Net loss	`ProfitLoss`	$-95.91K	USD	10 Qtrs
Net loss	`ProfitLoss`	$-50.11K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$7.50K	USD	Annual
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	-	USD	10 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$19.04K	USD	10 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$7.50K	USD	Annual
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$11.54K	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-33.79K	USD	Annual
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-76.86K	USD	10 Qtrs
Net Cash Used in Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-35.11K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$80.00K	USD	10 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$25.00K	USD	Annual
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	-	USD	Annual
Proceeds from related party debt	`ProceedsFromRelatedPartyDebt`	$380.00	USD	10 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$25.00K	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$80.38K	USD	10 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$3.52K	USD	10 Qtrs
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-8.79K	USD	Annual
Net Increase in Cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-35.11K	USD	Annual
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.52K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$12.31K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$3.52K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$47.42K	USD	Point-in-time
Cash, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Interest paid	`InterestPaid`	-	USD	10 Qtrs
Interest paid	`InterestPaid`	-	USD	Annual
Interest paid	`InterestPaid`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	10 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	-	USD	Annual

Stockholders Equity 13 line items

Line Item	Tag	Value	Unit	Period
Balance	`SharesOutstanding`	0.00	shares	Point-in-time
Balance	`SharesOutstanding`	54,541.00	shares	Point-in-time
Balance	`SharesOutstanding`	4,433.00	shares	Point-in-time
Balance	`SharesOutstanding`	-15,905.00	shares	Point-in-time
Balance	`SharesOutstanding`	0.00	shares	Point-in-time
Balance	`SharesOutstanding`	54,541.00	shares	Point-in-time
Balance	`SharesOutstanding`	4,433.00	shares	Point-in-time
Balance	`SharesOutstanding`	-15,905.00	shares	Point-in-time
Common stock issued for cash	`StockIssuedDuringPeriodSharesNewIssues`	55,000.00	shares	2 Qtrs
Common stock issued for cash	`StockIssuedDuringPeriodSharesNewIssues`	25,000.00	shares	Annual
Net loss.	`NetLoss`	$-50.11K	USD	Annual
Net loss.	`NetLoss`	$-45.34K	USD	Annual
Net loss.	`NetLoss`	$-459.00	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.